Suppr超能文献

使用51铬-乙二胺四乙酸测量肠道通透性。

Measurement of intestinal permeability using 51Cr-EDTA.

作者信息

Peled Y, Watz C, Gilat T

出版信息

Am J Gastroenterol. 1985 Oct;80(10):770-3.

PMID:3929593
Abstract

Intestinal permeability tests are a new class of tests of which the 51Cr-EDTA seemed the easiest to perform. We have evaluated the 8- and 24-h urinary excretion of ingested 51Cr-EDTA in 38 subjects. Twenty-seven patients with diseases not affecting the integrity of the small bowel served as controls. The test group consisted of two patients with celiac, six with Crohn's disease, and three with ulcerative colitis. Nineteen (70.37%) of the control patients had an abnormal test (more than 2.6% in 24 h). The patients with ulcerative colitis had normal excretion (mean 1.95% in 24 h). The patients with celiac disease had an elevated excretion (mean 3.62% in 24 h) and five out of six patients with Crohn's disease also had an increased excretion (mean 6.2% in 24 h). The elevated 51Cr-EDTA excretion in the control patients casts serious doubts on the validity of the test. Possible causes for abnormal excretion in the controls include various medications used by the patients as well as changes in the chromatographic mobility of 51Cr-EDTA, demonstrated by us after incubation with gastric juice.

摘要

肠道通透性测试是一类新型测试,其中51铬-乙二胺四乙酸(51Cr-EDTA)测试似乎最易于操作。我们评估了38名受试者摄入51Cr-EDTA后8小时和24小时的尿排泄情况。27名未影响小肠完整性的疾病患者作为对照。测试组包括2名乳糜泻患者、6名克罗恩病患者和3名溃疡性结肠炎患者。19名(70.37%)对照患者测试结果异常(24小时内超过2.6%)。溃疡性结肠炎患者排泄正常(24小时平均为1.95%)。乳糜泻患者排泄升高(24小时平均为3.62%),6名克罗恩病患者中有5名排泄也增加(24小时平均为6.2%)。对照患者中51Cr-EDTA排泄升高对该测试的有效性提出了严重质疑。对照中排泄异常的可能原因包括患者使用的各种药物以及我们在51Cr-EDTA与胃液孵育后所证实的其色谱迁移率的变化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验